Browse > Article
http://dx.doi.org/10.4014/jmb.2005.05017

Galectin-9 Induced by Dietary Prebiotics Regulates Immunomodulation to Reduce Atopic Dermatitis Symptoms in 1-Chloro-2,4-Dinitrobenzene (DNCB)-Treated NC/Nga Mice  

Kim, Jeong A (Department of Animal Resources Technology, Gyeongnam National University of Science and Technology)
Kim, Sung Hak (Department of Animal Science, Chonnam National University)
Kim, In Sung (Department of Animal Resources Technology, Gyeongnam National University of Science and Technology)
Yu, Da Yoon (Department of Animal Resources Technology, Gyeongnam National University of Science and Technology)
Kim, Gwang Il (Department of Animal Resources Technology, Gyeongnam National University of Science and Technology)
Moon, Yang Soo (Department of Animal Science and Biotechnology, Gyeongnam National University of Science and Technology)
Kim, Sung Chan (Department of Biochemistry, Institute of Cell Differentiation and Aging, College of Medicine, Hallym University)
Lee, Seung Ho (Department of Nano-Bioengineering, Incheon National University)
Lee, Sang Suk (Department of Animal Science and Technology, Sunchon National University)
Yun, Cheol-Heui (Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University)
Choi, In Soon (Department of Life Science, Silla University)
Cho, Kwang Keun (Department of Animal Resources Technology, Gyeongnam National University of Science and Technology)
Publication Information
Journal of Microbiology and Biotechnology / v.30, no.9, 2020 , pp. 1343-1354 More about this Journal
Abstract
Atopic dermatitis (AD) is a skin disorder that causes chronic itch. We investigated the inhibitory effects of a mixture of prebiotic short-chain galacto-oligosaccharides and long-chain fructooligosaccharides (scGOS/lcFOS), inulin, or β-glucan on AD development in 1-chloro-2,4-dinitrobenzene (DNCB)-treated NC/Nga mice. Mice were randomly assigned to six groups: untreated mice, AD control, positive control (DNCB-treated NC/Nga mice fed a dietary supplement of Zyrtec), and DNCB-treated NC/Nga mice fed a dietary supplement of prebiotics such as scGOS/lcFOS (T1), inulin (T2), or β-glucan (T3). The prebiotic treatment groups (T1, T2, and T3) showed suppression of AD symptoms, Th2 cell differentiation, and AD-like skin lesions induced by DNCB. In addition, prebiotic treatment also reduced the number of microorganisms such as Firmicutes, which is associated with AD symptoms, and increased the levels of Bacteroidetes and Ruminococcaceae, which are associated with alleviation of AD symptoms. Our findings demonstrate the inhibitory effects of prebiotics on AD development by improving the Th1/Th2 cytokine balance and beneficial symbiotic microorganisms in in vitro and in vivo models.
Keywords
Gut microbiota; immunomodulation; prebiotics; Th1 cells; Th2 cells; Treg cells;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Duncan SH, Louis P, Flint HJ. 2004. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70: 5810-5817.   DOI
2 Kim M, Kim JE, Yoon YS, Seo JG, Chung MJ, Yum DY. 2016. A probiotic preparation alleviates atopic dermatitis-like skin lesions in murine models. Toxicol. Res. 32: 149-158.   DOI
3 Ivanov II, Honda K. 2012. Intestinal commensal microbes as immune modulators. Cell Host Microbe 12: 496-508.   DOI
4 Candela M, Rampelli S, Turroni S, Severgnini M, Consolandi C, De Bellis G, et al. 2012. Unbalance of intestinal microbiota in atopic children. BMC Microbiol. 12: 95.   DOI
5 Darrigade AS, Legrand A, Andreu N, Jacquemin C, Boniface K, Taieb A, et al. 2018. Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata. Br. J. Dermatol. 179: 534-536.   DOI
6 Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. 2006. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38: 441-446.   DOI
7 Gavrilova T. 2018. Immune dysregulation in the Pathogenesis of atopic dermatitis. Dermatitis 29: 57-62.   DOI
8 Koberle M, Biedermann T. 2018. Microbiome, atopic eczema and blockade of type 2 immunity. Hautarzt 69: 197-203.   DOI
9 Barbarot S, Aubert H. 2017. Physiopathologie de la dermatite atopique: pathophysiology of atopic dermatits. Ann. Dermatol. Venereol. 144: 14-20.
10 Craig JM. 2016. Atopic dermatitis and the intestinal microbiota in humans and dogs. Vet. Med. Sci. 2: 95-105.   DOI
11 Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9: 313-323.   DOI
12 Shin JH, Chung MJ, Seo JG. 2016. A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of $CD4^+Foxp3^+$ T cells. Food Nutr. Res. 60: 32550.   DOI
13 Rastall RA, Gibson GR. 2015. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr. Opin. Biotechnol. 32: 42-46.   DOI
14 Wollina U. 2017. Microbiome in atopic dermatitis. Clin. Cosmet. Investig. Dermatol. 10: 51-56.   DOI
15 Carlson JL, Erickson JM, Lloyd BB, Slavin JL. 2018. Health effects and sources of prebiotic dietary fiber. Curr. Dev. Nutr. 2: nzy005.
16 Kim HJ, Lee SH, Go HN, Ahn JR, Kim HJ, Hong SJ. 2018. Effects of kestose on gut mucosal immunity in an atopic dermatitis mouse model. J. Dermatol. Sci. 89: 27-32.   DOI
17 Broom LJ, Kogut MH. 2018. Gut immunity: its development and reasons and opportunities for modulation in monogastric production animals. Anim. Health Res. Rev. 19: 46-52.   DOI
18 Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.   DOI
19 Hwang JS, Kim JE, Yu YB, Im SH. 2013. Modulation of experimental atopic dermatitis by topical application of Gami-Cheongyelul-Sodok-Eum. BMC Complement. Altern. Med. 13: 312.   DOI
20 van Hamburg JP, de Bruijn MJ, Ribeiro de Almeida C, van Zwam M, van Meurs M, de Haas E, et al. 2008. Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology. Eur. J. Immunol. 38: 2573-2586.   DOI
21 Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, et al. 2010. Generation of regulatory dendritic cells and $CD4^+Foxp3^+$ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. USA 107: 2159-2164.   DOI
22 Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. 2009. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 101: 541-550.   DOI
23 Chabot S, Kashio Y, Seki M, Shirato Y, Nakamura K, Nishi N, et al. 2002. Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12: 111-118.   DOI
24 Shin JH, Chung MJ, Seo JG. 2016. A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of $CD4^+Foxp3^+$ T cells. Food Nutr. Res. 60: 32550.   DOI
25 Fuller Z, Louis P, Mihajlovski A, Rungapamestry V, Ratcliffe B, Duncan AJ. 2007. Influence of cabbage processing methods and prebiotic manipulation of colonic microflora on glucosinolate breakdown in man. Br. J. Nutr. 98: 364-372.   DOI
26 Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. 2004. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 97: 1166-1177.   DOI
27 Yu DY, Kim SH, Kim JA, Kim IS, Moon YS, Lee SS, et al. 2018. Effects of Rubus coreanus byproducts on intestinal microbiota and the immune modulation. Asian-Australas. J. Anim. Sci. 31: 429-438.   DOI
28 Kim JE, Lee YK, Nam SH, Choi SI, Goo JS, Jang MJ, et al. 2010. The symptoms of atopic dermatitis in NC/Nga mice were significantly relieved by the water extract of Liriope platyphylla. Lab. Anim. Res. 26: 377-384.   DOI
29 de Kivit S, Saeland E, Kraneveld AD, van de Kant HJ, Schouten B, van Esch BC, et al. 2012. Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans. Allergy 67: 343-352.   DOI
30 Dhingra N, Guttman-Yassky E. 2014. A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis. J. Invest. Dermatol. 134: 2071-2074.   DOI
31 Amat F, Soria A, Tallon P, Bourgoin-Heck M, Lambert N, Deschildre A, et al. 2018. New insights into the phenotypes of atopic dermatitis linked with allergies and asthma in children: an overview. Clin. Exp. Allergy 48: 919-934.   DOI
32 de Kivit S, Kraneveld AD, Knippels LM, van Kooyk Y, Garssen J, Willemsen LE. 2013. Intestinal epithelium-derived galectin-9 is involved in the immunomodulating effects of nondigestible oligosaccharides. J. Innate Immun. 5: 625-638.   DOI
33 Marrs T, Sim K. 2018. Demystifying dysbiosis: Can the gut microbiome promote oral tolerance over IgE-mediated food allergy? Curr. Pediatr. Rev. 14: 156-163.   DOI
34 Marrs T, Flohr C. 2016. The role of skin and gut microbiota in the development of atopic eczema. Br. J. Dermatol. 175: 13-18.   DOI
35 Nylund L, Satokari R, Nikkila J, Rajilic-Stojanovic M, Kalliomaki M, Isolauri E, et al. 2013. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiol. 13: 12.   DOI
36 Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. 2012. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 129: 434-440.   DOI
37 Thomsen SF. 2014. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN. Allergy 2014: 354250.
38 Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107: 129-134.   DOI
39 Chua HH, Chou HC, Tung YL, Chiang BL, Liao CC, Liu HH, et al. 2018. Intestinal dysbiosis featuring abundance of Ruminococcus gnavus associates with allergic diseases in infants. Gastroenterology 154: 154-167.   DOI
40 Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, et al. 1998. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19: 359-361.   DOI
41 Sheikhi A, Giti H, Heibor MR, Jafarzadeh A, Shakerian M, Baharifar N, et al. 2017. Lactobacilus Delbrueckii subsp. Bulgaricus modulates the secretion of Th1/Th2 and Treg cell-related cytokines by PBMCs from patients with atopic dermatitis. Drug Res. (Stuttg) 67: 724-729.   DOI
42 Wallmeyer L, Dietert K, Sochorova M, Gruber AD, Kleuser B, Vavrova K, et al. 2017. TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents. Sci. Rep. 7: 774.   DOI
43 Purushothaman B, Arumugam P, Song JM. 2018. A novel catecholopyrimidine based small molecule PDE4B inhibitor suppresses inflammatory cytokines in atopic mice. Front. Pharmacol. 9: 485.   DOI
44 Cho KK, Choi IS. 2017. Allergy immunity regulation and synergism of Bifidobacteria. J. Life Sci. 27: 482-499.   DOI
45 West CE, Ryden P, Lundin D, Engstrand L, Tulic MK, Prescott SL. 2015. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin. Exp. Allergy 45: 1419-1429.   DOI
46 Krieg AM. 2008. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 27: 161-167.   DOI
47 Salem I, Ramser A, Isham N, Ghannoum MA. 2018. The gut microbiome as a major regulator of the gut-skin axis. Front. Microbiol. 9: 1459.   DOI
48 Pascal M, Perez-Gordo M, Caballero T, Escribese MM, Lopez Longo MN, Luengo O, et al. 2018. Microbiome and allergic diseases. Front. Immunol. 9: 1584.   DOI
49 Requena T , Martinez-Cuesta MC , Pelaez C. 2018. Diet and microbiota linked in health and disease. Food Funct. 9: 688-704.   DOI
50 Carrera-Quintanar L, Lopez Roa RI, Quintero-Fabian S, Sanchez-Sanchez MA, Vizmanos B, Ortuno-Sahagun D. 2018. Phytochemicals that influence gut microbiota as prophylactics and for the treatment of obesity and inflammatory diseases. Mediators Inflamm. 2018: 9734845.
51 Park SM, Choi WS, Yoon Y, Jung GH, Lee CK, Ahn SH, et al. 2018. Breast abscess caused by Staphylococcus aureus in 2 adolescent girls with atopic dermatitis. Korean J. Pediatr. 61: 200-204.   DOI
52 Ling Z, Li Z, Liu X, Cheng Y, Luo Y, Tong X, et al. 2014. Altered fecal microbiota composition associated with food allergy in infants. Appl. Environ. Microbiol. 80: 2546-2454.   DOI
53 Kim MH, Suh DI, Lee SY, Kim YK, Cho YJ, Cho SH. 2016. Microbiome research in food allergy and atopic dermatitis. Allergy Asthma Respir. Dis. 4: 389-398.   DOI
54 Johnson CC, Ownby DR. 2017. The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Transl. Res. 179: 60-70.   DOI
55 Bhute SS, Suryavanshi MV, Joshi SM, Yajnik CS, Shouche YS, Ghaskadbi SS. 2017. Gut microbial diversity assessment of indian Type-2-diabetics reveals alterations in eubacteria, archaea, and eukaryotes. Front. Microbiol. 8: 214.
56 Chang PV, Hao L, Offermanns S, Medzhitov R. 2014. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. USA 111: 2247-2252.   DOI
57 Shi Y, Xu LZ, Peng K, Wu W, Wu R, Liu ZQ, et al. 2015. Specific immunotherapy in combination with Clostridium butyricum inhibits allergic inflammation in the mouse intestine. Sci. Rep. 5: 17651.   DOI